Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling

Published:2021-03 Issue: Volume:20 Page:82-93
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Bu Huimin,Tan Shirui,Yuan Bo,Huang Xiaomei,Jiang Jiebang,Wu Yejiao,Jiang Jihong,Li Rongpeng

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Cancer treatment and survivorship statistics, 2019;Miller;CA Cancer J. Clin.,2019

3. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

4. Cancer incidence and mortality in China, 2014;Chen;Chin. J. Cancer Res.,2018

5. The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer;Ernani;Annu. Rev. Med.,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker discovery with quantum neural networks: a case-study in CTLA4-activation pathways;BMC Bioinformatics;2024-04-12

2. Synthesis, biological activity evaluation and mechanism of action of novel bis-isatin derivatives as potential anti-liver cancer agents;Bioorganic & Medicinal Chemistry Letters;2024-02

3. Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism;Pharmacological Research;2024-01

4. Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy;Biomedicine & Pharmacotherapy;2024-01

5. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer;Frontiers in Endocrinology;2023-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3